Navigation Links
Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
Date:11/14/2011

cond product candidate, which consists of a subcutaneously administered formulation of the specific Factor IXa inhibitor, pegnivacogin, (a.k.a. RB006), paired with an IV bolus formulation of its complementary active control agent, anivamersen, (a.k.a. RB007).  REG2 is anticipated to provide a favorable therapeutic profile with a slow onset of action and duration of effect lasting several days, ideally suited for venous thrombosis indications.

"Presenting such positive REG1 and REG2 data to an audience of industry peers at AHA validates the potential of Regado's science and pipeline," said David J. Mazzo, PhD, President and CEO of Regado.  "The RADAR trial results further demonstrate REG1's ability to promote early arterial sheath removal after cardiac catheterization without increasing time to hemostasis.  We believe this data provides additional validation of REG1's favorable profile as the only truly reversible anticoagulant in development."

"REG2 has also demonstrated significant potential for application in venous thrombosis indications, which is a commentary on our strong pipeline," Dr. Mazzo continued.

About Regado Biosciences

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent.  This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrom
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
2. Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
3. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
4. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
5. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
6. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
9. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
10. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
11. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... JERUSALEM , June 2, 2015 ... http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... a scientific abstract summarizing studies performed with ORMD-0801, its ... will be presented at the poster sessions in the ... 2015 in Boston . The poster ...
(Date:6/2/2015)... June 2, 2015  PROMETRIKA, LLC, a full-service ... with the addition of pharmacovigilance services for clinical ... in safety data collection and reporting, as our ... professionals, and expert physicians, each with more than ... and monitoring of safety trends. ...
(Date:6/2/2015)... VALLEY FORGE, Pa. , June 2, 2015 /PRNewswire/ ... plans to  build three new distribution centers in ... MN ; and Newburgh, NY ... strengthening the company,s ability to improve product access, increase ... Today,s announcement is part of the company,s ongoing ...
Breaking Medicine Technology:Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4PROMETRIKA Announces the Availability of Pharmacovigilance Services 2AmerisourceBergen to Build Three New Distribution Centers 2
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 The ... encouraged viewers to watch the station’s 6:00 a.m. Good Morning ... be entered on the station’s Facebook page. , ... other code-entering participants. She plans to apply the monthly ... months. Allen, a stay-at-home mom, expressed her surprise and ...
(Date:6/2/2015)... Ahmedabad, Gujarat, India (PRWEB) June 02, 2015 ... a finalist in the 2015 Microsoft Worldwide Small and ... a global field of top Microsoft partners for demonstrating ... on Microsoft technology. , “This comes as no ... expertise are recognized third year consecutively at worldwide level ...
(Date:6/2/2015)... 02, 2015 Milton Hershey School® graduate ... the 30 members of the Physician Assistant Program’s entering ... He was presented with a white coat, which symbolizes ... are extremely proud of Vincent’s accomplishments both at MHS ... a great example of how a top-notch education can ...
(Date:6/2/2015)... Warwick, RI (PRWEB) June 02, 2015 ... medical equipment distributor, has announced the acquisition of ... medical equipment distributor, effective May 29th, 2015. , With ... February 2015, this latest acquisition joins three premier organizations ... equipment to hospitals and healthcare facilities. By combining forces, ...
(Date:6/2/2015)... 2015 With a dedicated focus to become ... Care has hired Leslie Young as director of human ... initiatives to better understand and respond to the distinct needs ... communities in 13 states across the country. , “As we ... support to our residents, we are making it an equal ...
Breaking Medicine News(10 mins):Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... NORTH ANDOVER, Mass., Nov. 23 This time of year brings lots ... these feelings, both positive and negative, translate into urges to overeat as ... opportunities to do so all season long. , We may ... pie, but how many of us stop there? "That pie often ...
... first time, scientists have demonstrated that stem cells found ... to become specialized cell types, which suggests they may ... and conditions than scientists originally thought. Reporting in ... the research teams of Anthony Atala, M.D., director of ...
... The Institute ... its affiliated campuses in Florida. To locate a campus near you, please visit this webpage: ... ... are well into the third decade of Human Immunodeficiency Virus (HIV) epidemic and yet, with ...
... The Merriman Good Life Foundation ... awareness of the general public to the value of pets visiting residents of nursing homes and ... ... Daisy Project. The Daisy Project is aimed at raising awareness of the general public to ...
... ... Mansion in the exclusive community of Cherry Hills Village, Denver, CO, by Absolute Auction December ... Denver, ... Fentress, located in Cherry Hills Village in Denver, Colo., and you are immediately and keenly ...
... ... dental cleaner powerful enough to kill more than 99% of infection-causing bacteria found on ... ... found that mouthguards used regularly are highly contaminated with bacteria and microorganisms from staph ...
Cached Medicine News:Health News:Tis' the Season to Eat and Eat More! 2Health News:New research shows versatility of amniotic fluid stem cells 2Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 2Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 3Health News:,The Institute of Women's Health of North America Increases its Outreach by Offering Free and Confidential HIV Testing in Florida, 4Health News:Daisy Project Seeks To Increase Pet Visitation In Nursing Homes 2Health News:Barbara Fentress, Designer of the Denver International Airport and Convention Center, Offers Her Private Mansion at Absolute Auction 2Health News:DentaSOAK Dental Cleaner Reduces Infection Risk Linked to Mouthguards 2
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
... generation of a hypoxic environment for tissue ... surface-type seal where all portions of the ... steel ring clamp for a reliable air-tight ... and bottom provide minimum gas flow resistance ...
... range of miniTHERM incubators is available, ensuring ... solution for their specific requirements. miniTHERM incubators ... compact and extremely space saving. Their size ... It is possible to stack up to ...
... Steri-Cult has been the leading ... volume cell culture for more ... the name that brought leading ... CO 2 sensors,microprocessor control, ...
Medicine Products: